Drug Information

General Information
Drug ID
DR01208
Drug Name
Eprosartan
Synonyms
(4-carboxybenzyl)imidazole-5-acrylic acid; (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid; (E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid; (E)-4-((2-Butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1H-imidazol-1-yl)methyl)benzoic acid; (E)-alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid; 133040-01-4; 2KH13Z0S0Y; 4-({2-butyl-5-[(1E)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; 4-({2-butyl-5-[(1E)-2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; 4-[[2-butyl-5-[(E)-3-hydroxy-3-oxo-2-(thiophen-2-ylmethyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid; CHEBI:4814; CHEMBL813; Eprosartan (USAN/INN); Eprosartan [USAN:BAN:INN]; F 108566; F-108566; SK&F 108566; SK&F-108566; SK-108566; SKF-108566; Teveten; Teveten (TN); UNII-2KH13Z0S0Y; [3H]eprosartan
Drug Type
Small molecular drug
Indication High blood pressure [ICD11: BA00] Approved [1]
Therapeutic Class
Antihypertensive Agents
Structure
3D MOL 2D MOL
Formula
C23H24N2O4S
Canonical SMILES
CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O
InChI
InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+
InChIKey
OROAFUQRIXKEMV-LDADJPATSA-N
CAS Number
CAS 133040-01-4
Pharmaceutical Properties Molecular Weight 424.5 Topological Polar Surface Area 121
Heavy Atom Count 30 Rotatable Bond Count 10
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
XLogP
4.5
PubChem CID
5281037
PubChem SID
103213560 , 103924435 , 113854438 , 117814116 , 121277912 , 126682167 , 127329712 , 127329713 , 127329714 , 127329715 , 127329716 , 127329717 , 127329718 , 127329719 , 127329720 , 127329721 , 127329722 , 127329723 , 131835100 , 134223577 , 134338185 , 135026481 , 135650236 , 136367951 , 137002491 , 142300349 , 144115951 , 14929623 , 162161427 , 163389404 , 164814942 , 17398013 , 175266444 , 176484078 , 26757976 , 39289969 , 46506765 , 48415948 , 49658621 , 49830795 , 50064350 , 50303490 , 7979177 , 81092802 , 85209073 , 8616481 , 91612944 , 92308966 , 93166188 , 9670
ChEBI ID
ChEBI:4814
TTD Drug ID
D0T7US
DT(s) Transporting This Drug PEPT1 Transporter Info Peptide transporter 1 Substrate [2]
References
1 Eprosartan was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 High-affinity interaction of sartans with H+/peptide transporters. Drug Metab Dispos. 2009 Jan;37(1):143-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.